相关实验视频
Updated: May 27, 2025
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
289
中枢肺栓塞患者的临床特征和预后
Robin V Hofstetter1, Odile Stalder2, Tobias Tritschler1
1Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Journal of thrombosis and haemostasis : JTH
|February 16, 2025
概括
中心肺栓塞 (cPE) 将复发性静脉血栓塞 (VTE) 的风险增加2.2倍. 需要进一步的研究来确定延长抗凝剂是否可以减轻cPE患者这种增加的VTE复发风险.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 血管医学 血管医学
背景情况:
- 中心肺栓塞 (PE) 位置的临床意义尚不清楚.
- 中心PE (cPE) 涉及肺干或主要肺动脉中的栓塞.
- 了解cPE影响对于患者管理和预测结果至关重要.
研究的目的:
- 为了比较中心PE (cPE) 与非中心PE (非cPE) 患者的临床表现,风险因素和结果.
- 研究PE局部化与临床结果之间的关联,包括复发性静脉血栓塞栓症 (VTE) 和死亡率.
主要方法:
- 对来自SWITCO65+队列的597名急性PE患者 (2009-2013) 的回顾性分析.
- cPE定义为肺干或主要肺动脉中的栓塞.
- 基线特征和3个月/长期结果 (复发性VTE,死亡率,生活质量) 的比较,多变量调整.
主要成果:
- 36.3%的患者患有cPE,更频繁地出现呼吸困难,右心室功能障碍和心肌损伤.
- 根据PE的位置,在3个月的结果 (VTE复发,死亡率,生活质量) 中没有显著差异.
- 随访时间中位数为29.6个月,cPE与致死性PE风险更高 (5.5%与2.1%相比). 调整后的分析显示,cPE与增加的复发性静脉瘤相关 (SHR 2.22) 但没有整体死亡率 (HR 0.74).
结论:
- 与非cPE相比,中枢肺栓塞 (cPE) 与复发性VTE的风险增加了2.2倍.
- 这些发现表明,需要进一步研究CPE患者的最佳抗凝策略,以减少复发.
- 虽然cPE影响VTE复发,但其对整体死亡率的影响需要进一步澄清.
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
226
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
226
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:27Pneumothorax-II
117
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
117
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:28Pleural Effusion II: Symptoms and Management
150
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
150